Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial
Resource Type
Article
Authors
Ascierto, Paolo A ; Del Vecchio, Michele ; Mandalá, Mario ; Gogas, Helen ; Arance, Ana M ; Dalle, Stephane ; Cowey, C Lance ; Schenker, Michael ; Grob, Jean-Jacques ; Chiarion-Sileni, Vanna ; Márquez-Rodas, Iván ; Butler, Marcus O ; Maio, Michele ; Middleton, Mark R ; de la Cruz-Merino, Luis ; Arenberger, Petr ; Atkinson, Victoria ; Hill, Andrew ; Fecher, Leslie A ; Millward, Michael ; Khushalani, Nikhil I ; Queirolo, Paola ; Lobo, Maurice ; de Pril, Veerle ; Loffredo, John ; Larkin, James ; Weber, Jeffrey
Source
In The Lancet Oncology November 2020 21(11):1465-1477
Subject
Primary Research Articles
Language
ISSN
1470-2045